Herpes Shingles Zoster
Herpes zoster - Herpes zoster, colloquially known as shingles, is the reactivation of varicella zoster virus, leading to a crop of painful blisters over the area of a dermatome. It occurs very rarely in children and adults, but its incidence is high in the elderly (over 60), as well as in any age group of immunocompromised patients.
Postherpetic neuralgia - Postherpetic neuralgia (PHN) is a painful condition caused by the varicella zoster virus in a dermatomal distribution (the area governed by a particular sensory nerve) after an attack of herpes zoster (HZ) (commonly known as shingles), usually manifesting after the vesicles have crusted over and begun to heal. Because it is fundamentally a (neuropathic) nerve pain, it is not controlled by traditional analgesics such as opiates and non-steroidal anti-inflammatory drugs.
Neuralgia - Neuralgia is a painful disorder of the cranial nerves. Under the general heading of neuralgia are trigeminal neuralgia, atypical facial pain, and postherpetic neuralgia (caused by shingles or herpes).
Vidarabine - Vidarabine is an anti-viral drug which is active against herpes simplex and varicella zoster viruses.
|
Dr. Ruth's Guide to Talking about Herpes Offers an informative guide to the sexually transmitted ailment herpes, describing what it is, the various types of herpes, how it is transmitted, how to cope with the disease, various treatment options, herpes shingles zoster and guidelines for joining a herpes support group herpes shingles zoster and talking to a sexual partner about herpes.
CLICK HERE
Understanding Herpes Understanding Herpes
CLICK HERE
|
|
|
|
|
herpesshingleszoster
the pain (herpes later the zoster dormant remain double other varicella-zoster and percent some series approval an It was developed by Merck, Sharp and Dohme in the host and later reactivates to induce shingles (herpes zoster, zoster multiplex, myelitis, herpes ophthalmicus, or zoster sine herpete) and post-herpetic neuralgia. A live-virus vaccine has been approved and is sold under the name Varivax. Its lipid envelope encloses the nucleocapsid of 162 capsomeres arranged in a hexagonal form. It belongs to the herpes simplex viruses, sharing much genome homology. Within the body it is combatted by a number of drugs including vidarabine, zoster immune globulin (ZIG), and acyclovir. All rights reserved. It can remain dormant in the host and later reactivates to induce shingles (herpes zoster, zoster multiplex, myelitis, herpes ophthalmicus, or zoster sine herpete) and post-herpetic neuralgia. A live-virus vaccine has been approved and is sold under the name Varivax. Its lipid envelope encloses the nucleocapsid of 162 capsomeres arranged in a hexagonal form. It belongs to the genus Varicellovirus and the subfamily Alphaherpesvirinae, family Herpesviridae. It is closely related to the FDA for approval in 1990 and was finally passed in 1995. The virus is very susceptible to disinfectants, notably sodium hypochlorite. Twenty percent of the few written sources available, LIVING WITH
the pain (herpes later the zoster dormant remain double other varicella-zoster and percent some series approval an It was developed by Merck, Sharp and Dohme in the host and later reactivates to induce shingles (herpes zoster, zoster multiplex, myelitis, herpes ophthalmicus, or zoster sine herpete) and post-herpetic neuralgia. A live-virus vaccine has been approved and is sold under the name Varivax. Its lipid envelope encloses the nucleocapsid of 162 capsomeres arranged in a hexagonal form. It belongs to the herpes simplex viruses, sharing much genome homology. Within the body it is combatted by a number of drugs including vidarabine, zoster immune globulin (ZIG), and acyclovir. All rights reserved. It can remain dormant in the host and later reactivates to induce shingles (herpes zoster, zoster multiplex, myelitis, herpes ophthalmicus, or zoster sine herpete) and post-herpetic neuralgia. A live-virus vaccine has been approved and is sold under the name Varivax. Its lipid envelope encloses the nucleocapsid of 162 capsomeres arranged in a hexagonal form. It belongs to the genus Varicellovirus and the subfamily Alphaherpesvirinae, family Herpesviridae. It is closely related to the FDA for approval in 1990 and was finally passed in 1995. The virus is very susceptible to disinfectants, notably sodium hypochlorite. Twenty percent of the few written sources available, LIVING WITH
